Karyopharm announces the appointment of brendan strong as senior vice president of investor relations and corporate communications

Newton, mass. , dec. 9, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of brendan strong as senior vice president of investor relations and corporate communications.
KPTI Ratings Summary
KPTI Quant Ranking